The chapter explores the evolution of societal progress, focusing on women's rights developments in the United States since 1971, and discusses ethical dilemmas related to CRISPR, gene therapy, and the precautionary principle, including reactions to embryo projects and patient experiences seeking to avoid genetic mutations in children.
Noor Siddiqui is currently building Orchid, a reproductive technology company that measures genetic predisposition to disease and provides embryo screening for couples going through IVF.
Noor joins the show to discuss the ambitious culture of the West Coast, getting into the Thiel Fellowship, her personal reasons for starting Orchid, the sacred act of reproduction and why it must be made safe, her belief in children as the future, and MUCH more!
Important Links:
Show Notes:
- The Ambitious Culture of San Francisco
- The East Coast Aversion to Risky Ambition
- The Intimate Origin Story of Orchid
- What Orchid Has Built
- The History and Controversy Around Reproductive Technology
- Surprising Aspects of Orchid’s Technology
- Benefits of Saliva Testing
- Making Our Own Genetic Luck
- Noor’s Predictions for the Field
- Advances in Embryonic Freezing
- Why Noor Values Clear Writing
- Noor as Empress of the World
- MORE!
Books/Essays Mentioned: